JPS6259783B2 - - Google Patents

Info

Publication number
JPS6259783B2
JPS6259783B2 JP55067975A JP6797580A JPS6259783B2 JP S6259783 B2 JPS6259783 B2 JP S6259783B2 JP 55067975 A JP55067975 A JP 55067975A JP 6797580 A JP6797580 A JP 6797580A JP S6259783 B2 JPS6259783 B2 JP S6259783B2
Authority
JP
Japan
Prior art keywords
mif
mif antigen
antigen
immunization
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55067975A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55158560A (en
Inventor
Jeen Buranto Eba
Shimon Asukyurei Samueru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of JPS55158560A publication Critical patent/JPS55158560A/ja
Publication of JPS6259783B2 publication Critical patent/JPS6259783B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A23L29/219—Chemically modified starch; Reaction or complexation products of starch with other chemicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Optical Communication System (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP6797580A 1979-05-25 1980-05-23 Radioimmunoassay method Granted JPS55158560A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/042,662 US4299814A (en) 1979-05-25 1979-05-25 Radioimmunoassay of MIF

Publications (2)

Publication Number Publication Date
JPS55158560A JPS55158560A (en) 1980-12-10
JPS6259783B2 true JPS6259783B2 (enExample) 1987-12-12

Family

ID=21923107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6797580A Granted JPS55158560A (en) 1979-05-25 1980-05-23 Radioimmunoassay method

Country Status (6)

Country Link
US (1) US4299814A (enExample)
EP (1) EP0020090B1 (enExample)
JP (1) JPS55158560A (enExample)
KR (1) KR830002333A (enExample)
AT (1) ATE9846T1 (enExample)
DE (1) DE3069404D1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4403041A (en) * 1979-03-15 1983-09-06 Ciba-Geigy Corporation Diagnosis of atherosclerosis
JPH0672158B2 (ja) * 1984-05-24 1994-09-14 チバ−ガイギ− アクチエンゲゼルシヤフト 精製されたヒトマクロファージ遊走阻止因子
US6030615A (en) * 1993-05-17 2000-02-29 The Picower Institute For Medical Research Combination method for treating diseases caused by cytokine-mediated toxicity
US6774227B1 (en) * 1993-05-17 2004-08-10 Cytokine Pharmasciences, Inc. Therapeutic uses of factors which inhibit or neutralize MIF activity
MY140679A (en) * 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
WO2003047622A1 (fr) * 2001-11-30 2003-06-12 Jun Nishihira Remedes pour la sclerose en plaques
KR100530611B1 (ko) * 2002-11-22 2005-11-22 한국원자력연구소 대식세포 유주저지인자의 농도 측정을 위한 방사면역측정법
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AU2004268941A1 (en) * 2003-08-22 2005-03-10 Avanir Pharmaceuticals Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
WO2005082008A2 (en) * 2004-02-25 2005-09-09 The United States Of America As Represented By The Department Ofveterans Affairs Methods for diagnosing and treating bladder cancer
EP1861407A1 (en) * 2005-03-24 2007-12-05 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
AU2012320597C1 (en) 2011-10-07 2015-10-15 Baxalta GmbH oxMIF as a diagnostic marker

Also Published As

Publication number Publication date
KR830002333A (ko) 1983-05-28
EP0020090B1 (en) 1984-10-10
US4299814A (en) 1981-11-10
ATE9846T1 (de) 1984-10-15
DE3069404D1 (en) 1984-11-15
JPS55158560A (en) 1980-12-10
EP0020090A1 (en) 1980-12-10

Similar Documents

Publication Publication Date Title
Dinarello et al. Human leukocytic pyrogen: purification and development of a radioimmunoassay.
US4353982A (en) Immunochemical assay for creatine kinase-MB isoenzyme
Nopparatana et al. Purification of Gnathostoma spinigerum specific antigen and immunodiagnosis of human gnathostomiasis
WO1983004312A1 (en) Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
Hanson et al. Characterization of antibodies in human urine
US4264571A (en) Radioimmunoassay of thymosin α1
JPS6259783B2 (enExample)
JPS6357599A (ja) イヌ心糸状虫ワクチンおよび診断試験
Herscowitz et al. Immunochemical and immunogenic properties of a purified keyhole limpet haemocyanin
JPH05255390A (ja) オリゴペプチド接合体
Collins et al. Rapid solid-phase radioimmunoassay for staphylococcal enterotoxin A
US5780298A (en) DNA encoding the sn-RNP-A antigen and fragments thereof
AU773675B2 (en) Method for analyzing the amount of intraabdominal adipose tissue
Yuan et al. Molecular forms of antigen in the circulation following immunization
Enami et al. A sensitive radioimmunoassay for a component of mouse casein
JPH04507285A (ja) 抗イディオトープ免疫検定法
EP0229723A2 (en) Modified Beta 2-microglobulin
US5175113A (en) Modified β2 -microglobulin
Ballmer-Hofer et al. Isolation of in situ crosslinked ligand-receptor complexes using an anticrosslinker specific antibody
Khayam-Bashi et al. Chromatographic separation and purification of secretory IgA from human milk
Kamboh et al. Genetic studies of low-abundance human plasma proteins. I. Microheterogeneity of zinc-α 2-glycoprotein in biological fluids
Sibinovic IMMUNOGENIC PROPERTIES OF PURIFIED ANTIGENS ISOLATED FROM THE SERUM OF HORSES, DOGS AND RATS WITH ACUTE BABESIOSIS.
Chang et al. The purification of human chorionic gonadotropin on DEAE-Sephadex
Motte et al. A two-site immunoradiometric assay for serum calcitonin using monoclonal anti-peptide antibodies
Manski et al. Comparison of α-crystallin A and B chains in their dissociated and associated states